Warrant Inducement Agreement Sample Contracts
HEPION PHARMACEUTICALS, INC. Edison, NJ 08837Warrant Inducement Agreement • February 16th, 2024 • Hepion Pharmaceuticals, Inc. • Pharmaceutical preparations
HEPION PHARMACEUTICALS, INC. (the “Company”) is pleased to offer (this “Offer”) to you (“Holder”, “you” or similar terminology) the opportunity to receive new common stock purchase warrants (the “New Warrants”) to purchase up an aggregate of 1,470,590 shares (collectively, the “New Warrant Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), equal to 150% of the 980,393 shares of Common Stock (such shares, collectively, the “Warrant Shares”) issuable pursuant to the exercise of that certain Series B Common Stock Purchase Warrant, currently held by you and issued to you on October 3, 2023 (the “Existing Warrant”), as more particularly set forth on the signature page hereto, in consideration for exercising for cash all of the Existing Warrant (which currently has an exercise price per share of $4.85) at an exercise price per share of $2.10 (with such exercise price being established for purposes of compliance with Nasdaq Stock Market listing rules)
Amendment to Warrant Inducement AgreementWarrant Inducement Agreement • January 8th, 2025 • Cn Energy Group. Inc. • Industrial organic chemicals • New York
This Amendment to Warrant Inducement Agreement (this “Agreement”) is made and entered into as of January 7, 2025, by and between CN ENERGY GROUP. INC. (the “Company”) and the party identified on the signature pages hereto (the “Holder”, together with the Company, collectively the “Parties” and each a “Party”), who is a holder of the Company’s existing ordinary share purchase warrants issued in January 2023 (the “Existing Warrants”).